POSC116 Economic Evaluation of Cefiderocol in Patients with Confirmed Carbapenem-Resistant Infections in the Italian Healthcare System

Abstract

Authors

M Bassetti ML Notarianni A Pitrelli A Dymond W Green S Lopes K Gill

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×